9:22 AM
Leo Group India
| ||
| Spectrum Pharmaceuticals to Present at the Jefferies 2012 Global Healthcare ... MarketWatch (press release) HENDERSON, Nev., May 31, 2012 (BUSINESS WIRE) -- Spectrum Pharmaceuticals (nasdaqgs:SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, announced today that an ... See all stories on this topic » | ||
| Catabasis Pharmaceuticals Appoints Henry Rath to Vice President, Business ... MarketWatch (press release) CAMBRIDGE, Mass., May 31, 2012 (BUSINESS WIRE) -- Catabasis Pharmaceuticals, a clinical stage biopharmaceutical company dedicated to the discovery and development of innovative, effective and safe medicines for the treatment of inflammatory and ... See all stories on this topic » | ||
| La Jolla Pharmaceutical Announces Issuance of US Patent Covering Modified ... MarketWatch (press release) SAN DIEGO, CA, May 31, 2012 (MARKETWIRE via COMTEX) -- La Jolla Pharmaceutical Company (otcqb:LJPC) (pinksheets:LJPC) (the "Company" and "La Jolla") announced today that the United States Patent and Trademark Office (USPTO) has issued patent number ... See all stories on this topic » | ||
| Veloxis Pharmaceuticals to Present Results from a Patient Subgroup Analysis of ... MarketWatch (press release) HORSHOLM, Denmark, May 31, 2012 /PRNewswire via COMTEX/ -- Veloxis Pharmaceuticals A/S (omx:VELO) today announced that a subgroup analysis of African-American stable kidney transplant patients enrolled in Study 3001, a Phase 3 non-inferiority study, ... See all stories on this topic » | ||
| US FDA warns consumers & healthcare professionals about counterfeit version of ... pharmabiz.com The US Food and Drug Administration (FDA) has issued a warnings to consumers and healthcare professionals about a counterfeit version of Teva Pharmaceutical Industries' Adderall 30 milligram tablets that is being purchased on the Internet. See all stories on this topic » | ||
| Biostar Pharmaceuticals, Inc. Provides Update Regarding Gel Capsule Safety Issues Sacramento Bee By Biostar Pharmaceuticals, Inc. XIANYANG, China, May 30, 2012 -- /PRNewswire-Asia/ -- Biostar Pharmaceuticals, Inc. (NASDAQ GM: BSPM) ("Biostar" or "the Company"), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products ... See all stories on this topic » | ||
| CSD reports continued growth in pharmaceutical marketing investments in Brazil ... MarketWatch (press release) Both Brazil and China showed marked increases in pharmaceutical marketing investments for 2011, despite a decline of more than 3% in worldwide investments. Brazil, one of the fastest-growing emerging markets, had total investments of US $4.4bn, ... See all stories on this topic » | ||
| Taiho Pharmaceutical Announces Start of Global Phase III Clinical Trial in ... Sacramento Bee By Taiho Pharmaceutical Co., Ltd. TOKYO, May 31, 2012 -- /PRNewswire/ -- Taiho Pharmaceutical Co., Ltd. announced on May 31 that a global Phase III clinical trial (RECOURSE) for the novel combination antimetabolite TAS-102 will start in June this year. See all stories on this topic » |
Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment